David Cordani

David Cordani has served as Chairman and CEO of The Cigna Group since 2009, leading the health services company through a fundamental transformation of its business model. His most consequential strategic move was the $67 billion acquisition of Express Scripts in 2018, which transformed Cigna from a health insurance company into a health services conglomerate with the Evernorth pharmacy benefits management (PBM), specialty pharmacy, and care delivery platform generating the majority of revenue. Cordani's second transformative decision came in 2024 when he announced the sale of Cigna's Medicare Advantage and individual insurance businesses to Elevance Health for $13 billion. This divestiture effectively exited Cigna from government-sponsored health insurance, allowing the company to concentrate entirely on Evernorth's health services and the Cigna Healthcare employer-sponsored business. Under Cordani's leadership, Cigna has delivered consistent earnings growth through Evernorth's pharmacy services (processing over 1.5 billion prescriptions annually), specialty pharmacy (one of the largest in the U.S.), and employer health plan administration. His decisions on Evernorth growth strategy, biosimilar and GLP-1 drug pricing management, PBM transparency amid regulatory scrutiny, and capital allocation are the primary drivers of Cigna's stock.